In this article, we will discuss the 12 Best Get Rich Quick Stocks to Buy According to Hedge Funds. On March 9, Main Management CEO and Portfolio Manager Kim Arthur joined CNBC’s ‘Halftime Report’ to ...

For Andrew Hall, a veteran of Big Pharma-turned biotech builder, he has spent much of his recent career operating inside those constraints — and learning how to lead through them. Today, as CEO of ...

Ultragenyx said that the trial of the gene therapy will continue while data from the second primary endpoint is collected.

Q4 2025 Management View David Luci, President and CEO, highlighted a series of corporate milestones, including the receipt of $1.4 million in gross proceeds from the execution of Series F Warrants in ...

This biotech specializes in therapies for neurological disorders, advancing a diverse pipeline through late-stage trials and collaborations.

In this video from the Macula Society meeting, Theodore Leng, MD, FACS, discusses research on managing coexisting geographic atrophy and neovascular age-related macular degeneration in the same eye.

AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate Update Phase 2 interim results suggest treatment with active immunotherapy ACI-7104 may slow the progression of Parkinson's ...

Introduction Psychedelic-assisted therapy shows promise for treating various mental health conditions; however, its reliance on intensive psychological preparation limits its broader application.

AI search visibility across healthcare websites is not collapsing. It is being reclassified and redistributed across AI ...

G&A Expenses -- $13.8 million in the fourth quarter, of which $5.6 million was non-cash stock-based compensation; annual G&A ...

Registered clinical exercise physiologists (CEPs) are recognised healthcare professionals in the UK and are registered through the Academy of Healthcare Science (AHCS). Their practice is guided by the ...

Q4 2025 Earnings Call March 12, 2026 4:30 PM EDTCompany ParticipantsJennie WillsonJacqueline Shea - CEO, President ...